Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Burning Rock Biotech Limi...

    NASDAQ: BNR · Real-Time Price · USD
    3.78
    0.40 (11.67%)
    At close: Jun 17, 2025, 12:38 PM

    Burning Rock Biotech Statistics

    Share Statistics

    Burning Rock Biotech has 1.08M shares outstanding. The number of shares has increased by 0.14% in one year.

    Shares Outstanding

    n/a
    		 1.08M

    Shares Change (YoY)

    n/a
    		 0.14%

    Shares Change (QoQ)

    n/a
    		 2.94%

    Owned by Institutions (%)

    n/a
    		 0.21%

    Shares Floating

    n/a
    		 1.07M

    Failed to Deliver (FTD) Shares

    n/a
    		 870

    FTD / Avg. Volume

    n/a
    		 2.2%

    Short Selling Information

    The latest short interest is 39.99K, so 0.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 39.99K

    Short % of Shares Out

    n/a
    		 0.39%

    Short % of Float

    n/a
    		 0.54%

    Short Ratio (days to cover)

    n/a
    		 2.11

    Valuation Ratios

    The PE ratio is -0.15 and the forward PE ratio is null. Burning Rock Biotech's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.15

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.1

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.09

    P/FCF Ratio

    n/a
    		 -0.52

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Burning Rock Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 2.92

    Quick Ratio

    n/a
    		 2.71

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 -0.19

    Debt / FCF

    n/a
    		 -0.53

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $765,314.54

    Profits Per Employee

    n/a
    		 $-514,281.9

    Employee Count

    n/a
    		 674

    Asset Turnover

    n/a
    		 0.58

    Inventory Turnover

    n/a
    		 2.85

    Taxes

    Income Tax

    n/a
    		 5.88M

    Effective Tax Rate

    n/a
    		 -1.73%

    Stock Price Statistics

    The stock price has increased by -54.14% in the last 52 weeks. The beta is 0.74, so Burning Rock Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.74

    52-Week Price Change

    n/a
    		 -54.14%

    50-Day Moving Average

    n/a
    		 2.98

    200-Day Moving Average

    n/a
    		 4.63

    Relative Strength Index (RSI)

    n/a
    		 54.13

    Average Volume (20 Days)

    n/a
    		 39,530

    Income Statement

    In the last 12 months, Burning Rock Biotech had revenue of 515.82M and earned -346.63M in profits. Earnings per share was -341.5.

    Revenue

    n/a
    		 515.82M

    Gross Profit

    n/a
    		 362.4M

    Operating Income

    n/a
    		 -357.56M

    Net Income

    n/a
    		 -346.63M

    EBITDA

    n/a
    		 -270.23M

    EBIT

    n/a
    		 -322.43M

    Earnings Per Share (EPS)

    n/a
    		 -341.5
    Full Income Statement

    Balance Sheet

    The company has 519.85M in cash and 52.32M in debt, giving a net cash position of 467.53M.

    Cash & Cash Equivalents

    n/a
    		 519.85M

    Total Debt

    n/a
    		 52.32M

    Net Cash

    n/a
    		 467.53M

    Retained Earnings

    n/a
    		 -4.2B

    Total Assets

    n/a
    		 885.3M

    Working Capital

    n/a
    		 510.32M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -92.26M and capital expenditures -5.98M, giving a free cash flow of -98.24M.

    Operating Cash Flow

    n/a
    		 -92.26M

    Capital Expenditures

    n/a
    		 -5.98M

    Free Cash Flow

    n/a
    		 -98.24M

    FCF Per Share

    n/a
    		 -9.54
    Full Cash Flow Statement

    Margins

    Gross margin is 70.26%, with operating and profit margins of -69.32% and -67.2%.

    Gross Margin

    n/a
    		 70.26%

    Operating Margin

    n/a
    		 -69.32%

    Pretax Margin

    n/a
    		 -66.06%

    Profit Margin

    n/a
    		 -67.2%

    EBITDA Margin

    n/a
    		 -52.39%

    EBIT Margin

    n/a
    		 -69.32%

    FCF Margin

    n/a
    		 -19.04%

    Dividends & Yields

    BNR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BNR.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 15, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 May 15, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -6.56

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist